Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment of Suspected Rubella Virus-Associated Granulomatous Dermatitis With Adalimumab.

JAMA dermatology·2025
Same author

Pink Ulcerated Nodule on the Forearm.

Cutis·2025
Same author

The Long Haul to Surgery: Long COVID Has Minimal Burden on Surgical Departments.

International journal of environmental research and public health·2024
Same author

Integrated Genomic and Social Network Analyses of SARS-CoV-2 Transmission in the Healthcare Setting.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2024
Same author

Blasts with folded nuclei: A histopathologic finding in myeloid leukemia cutis with NPM1 and FLT3 mutations.

Journal of cutaneous pathology·2023
Same author

Bullous Systemic Lupus Erythematosus With Lupus Nephritis.

Mayo Clinic proceedings·2023

Related Experiment Video

Updated: May 16, 2026

Cutaneous Leishmaniasis in the Dorsal Skin of Hamsters: a Useful Model for the Screening of Antileishmanial Drugs
11:36

Cutaneous Leishmaniasis in the Dorsal Skin of Hamsters: a Useful Model for the Screening of Antileishmanial Drugs

Published on: April 21, 2012

Intermediate/borderline disseminated cutaneous leishmaniasis.

Alberto E Paniz Mondolfi1, Gabrielle Baker Duffey, Lucy E Horton

  • 1Department of Dermatology, Tufts Medical Center and Miraca Life Sciences, Boston, MA, USA. albertopaniz@yahoo.com

International Journal of Dermatology
|December 13, 2012
PubMed
Summary
This summary is machine-generated.

Intermediate cutaneous leishmaniasis, prevalent in Latin America, presents challenging chronic lesions and treatment resistance. This review details its classification, transmission, clinical aspects, immunology, and therapeutic strategies.

Related Experiment Videos

Last Updated: May 16, 2026

Cutaneous Leishmaniasis in the Dorsal Skin of Hamsters: a Useful Model for the Screening of Antileishmanial Drugs
11:36

Cutaneous Leishmaniasis in the Dorsal Skin of Hamsters: a Useful Model for the Screening of Antileishmanial Drugs

Published on: April 21, 2012

Area of Science:

  • Parasitology
  • Infectious Diseases
  • Dermatology

Background:

  • Leishmaniasis encompasses diverse vector-borne diseases caused by Leishmania protozoa.
  • Cutaneous leishmaniasis presents in localized, intermediate, and diffuse forms.
  • Intermediate cutaneous leishmaniasis is common in Latin America.

Observation:

  • Characterized by cutaneous lesions, potentially with mucosal involvement.
  • Exhibits chronicity, relapse, and resistance to standard treatments.
  • Leishmania parasites from the subgenus Viannia are primary causative agents.

Findings:

  • This review synthesizes information on classification, transmission, and clinical presentation.
  • It examines disease evolution, host immunology, and current treatment options.
  • Focuses specifically on the intermediate/borderline disseminated form of cutaneous leishmaniasis.

Implications:

  • Understanding these aspects is crucial for effective management of leishmaniasis.
  • Highlights the need for novel therapeutic strategies due to treatment resistance.
  • Informs public health efforts for controlling this neglected tropical disease.